Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes

被引:128
作者
Maratheftis, Christos I.
Andreakos, Evangelos
Moutsopoulos, Haralampos M.
Voulgarelis, Michael
机构
[1] Natl Univ Athens, Dept Pathophysiol, Sch Med, Athens 11527, Greece
[2] Acad Athens, Dept Immunol & Transplantat, Fdn Biomed Res, Athens, Greece
关键词
D O I
10.1158/1078-0432.CCR-06-2108
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the function and expression of Toll-like receptors (TLR) in bone marrow cells of myelodysplastic syndrome (MDS) patients and to examine their involvement in the apoptotic phenomenon characterizing MDS hematopoiesis. Experimental Design: TLR mRNA and protein expression was investigated in bone marrow cell populations of MDS patients and controls. TLR-4 ability to recognize lipopolysaccharide and upregulate self mRNA and protein expression was examined. Tumor necrosis factor involvement in the constitutive and lipopolysaccharide (LPS) -induced TLR expression was also evaluated. Possible correlation between TLR-4 overexpression and apoptosis was investigated by simultaneous staining with Annexin V and TLR-4. Results: TLR-2 and TLR-4 are expressed in almost all bone marrow cell lineages including megakaryocytes, erythroid cells, myeloid precursors, monocytes, and B lymphocytes and are upregulated in MDS patients compared with controls. In hematopoietic CD34(+) cells,TLR-4 is also expressed and significantly up-regulated at both the mRNA and protein levels. Treatment with an anti - tumor necrosis factor antibody reduces both constitutive and LPS-induced TLR-4 levels. Increased TLR-4 expression correlates with increased apoptosis as TLR-4 is almost exclusively found in apoptotic bone marrow mononuclear and CD34(+) cells. The addition of the TLR-4 ligand LPS further enhances the apoptosis of these cells. Conclusions: TLR-4 and other TLRs are significantly up-regulated in MDS patients whereas TLR-4 is involved in promoting apoptosis, possibly contributing to MDS cytopenia.
引用
收藏
页码:1154 / 1160
页数:7
相关论文
共 27 条
[1]   Toll-like receptors in the induction of the innate immune response [J].
Aderem, A ;
Ulevitch, RJ .
NATURE, 2000, 406 (6797) :782-787
[2]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[3]   The apoptotic signaling pathway activated by Toll-like receptor-2 [J].
Aliprantis, AO ;
Yang, RB ;
Weiss, DS ;
Godowski, P ;
Zychlinsky, A .
EMBO JOURNAL, 2000, 19 (13) :3325-3336
[4]   Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? [J].
Andreakos, E ;
Foxwell, B ;
Feldmann, M .
IMMUNOLOGICAL REVIEWS, 2004, 202 :250-265
[5]   Expression of FLIPLong and FLIPShort in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome:: correlation with apoptosis [J].
Benesch, M ;
Platzbecker, U ;
Ward, J ;
Deeg, HJ ;
Leisenring, W .
LEUKEMIA, 2003, 17 (12) :2460-2466
[6]   A comparative review of classification systems in myelodysplastic syndromes (MDS) [J].
Bennett, JM .
SEMINARS IN ONCOLOGY, 2005, 32 (04) :S3-S10
[7]   Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes [J].
Campioni, D ;
Secchiero, P ;
Corallini, F ;
Melloni, E ;
Capitani, S ;
Lanza, F ;
Zauli, G .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (02) :557-563
[8]   In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis [J].
Claessens, YE ;
Bouscary, D ;
Dupont, JM ;
Picard, F ;
Melle, J ;
Gisselbrecht, S ;
Lacombe, C ;
Dreyfus, F ;
Mayeux, P ;
Fontenay-Roupie, M .
BLOOD, 2002, 99 (05) :1594-1601
[9]   Overexpression of TLR2 and TLR4 susceptibility to serum deprivation-induced apoptosis in CHO cells [J].
Fan, W ;
Ha, TZ ;
Li, Y ;
Ozment-Skelton, T ;
Williams, DL ;
Kelley, J ;
Browder, IW ;
Li, CF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 337 (03) :840-848
[10]   Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival [J].
Gupta, P ;
Niehans, GA ;
LeRoy, SC ;
Gupta, K ;
Morrison, VA ;
Schultz, C ;
Knapp, DJ ;
Kratzke, RA .
LEUKEMIA, 1999, 13 (01) :44-53